Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

Age-related macular degeneration (AMD) is one of the leading causes of vision ... which can rapidly damage the macula. There is no cure for dry AMD, though lifestyle modifications and supplements may ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...

In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...

Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the price ...

Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...